FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2561875875> ?p ?o ?g. }

• W2561875875 endingPage "3233" @default.
• W2561875875 startingPage "3233" @default.
• W2561875875 abstract "Abstract Abstract 3233 Indoleamine 2,3-dioxygenase (IDO) is the rate-limiting enzyme in tryptophan catabolism along the kynurenine pathway. IDO expressed by different cell subsets inhibits T-cell activation, proliferation and survival and induces regulatory T cells (Tregs), thus mediating immunological tolerance. Although human monocyte-derived dendritic cells (DCs) have been shown to express IDO, little is known about its expression in other subsets of human DCs, including those generated from CD34+ hematopoietic progenitors (CD34+-derived DCs). In particular, no data are currently available for IDO expression in CD34+-derived DC subsets. CD34+-derived DCs were generated from healthy donors from purified CD34+ cells after 7 days of culture with GM-CSF and TNF-a. Then, DCs were separated into CD1a−CD14+ and CD1a+CD14− cells. DCs subsets were analyzed for IDO expression by real-time PCR and western immunoblot, kynurenine production, inhibition of allogeneic proliferation and Tregs induction. CD34+ cells did not express IDO mRNA expression regardless of the progenitor cell sources (cord blood, mobilized peripheral blood, bone marrow). During DC differentiation, IDO expression and function, evaluated by enzymatic and immunological tests, was markedly induced at day 7. Interestingly, the expression of IDO was shown to be 10 times higher in the CD1a+ compartment as compared to CD1a- cell fraction. IDO expression resulted in increased production of kynurenine and in reduced allostimulatory capacity of T-cell proliferation. Moreover, CD1a+ cells were shown to induce a population of CD4+CD25+Foxp3+ which acted as Tregs by inhibiting allogeneic T cell proliferation. This effect was abrogated by the addition of the IDO inhibitor 1-methyl tryptophan. Phenotypically, IDO-expressing CD1a+ cells expressed typical marker of Langerhans cells such as CD207, CD11b, CD1c, as well as CD103, which has been recently identified as a marker for tolerogenic DCs. Importantly, IDO expression was mainly detected in the CD103+ CD207+ fraction, which induces Tregs through an IDO-dependent manner. In conclusion, DC differentiation of CD34+ cells results in the expression of a functionally active IDO protein in CD103-expressing DCs. Given the role of IDO in regulating immune tolerance, a subset of bone marrow-derived DCs, expressing CD103, may be intrinsically committed to function as regulatory DCs. These data point toward IDO expression as part of a tolerogenic signature during DC development. Disclosures: No relevant conflicts of interest to declare." @default.
• W2561875875 created "2017-01-06" @default.
• W2561875875 creator A5002381343 @default.
• W2561875875 creator A5035821112 @default.
• W2561875875 creator A5044224344 @default.
• W2561875875 creator A5044355450 @default.
• W2561875875 creator A5055349649 @default.
• W2561875875 creator A5072253025 @default.
• W2561875875 creator A5083844423 @default.
• W2561875875 date "2011-11-18" @default.
• W2561875875 modified "2023-10-18" @default.
• W2561875875 title "Integrin Alpha E (CD103) Beta 7 Expression Marks A Subset of Human Bone Marrow-Derived CD207+ Dendritic Cells Which Induce T Regulatory Cells Via Indoleamine 2,3-Dioxygenase," @default.
• W2561875875 doi "https://doi.org/10.1182/blood.v118.21.3233.3233" @default.
• W2561875875 hasPublicationYear "2011" @default.
• W2561875875 type Work @default.
• W2561875875 sameAs 2561875875 @default.
• W2561875875 citedByCount "0" @default.
• W2561875875 crossrefType "journal-article" @default.
• W2561875875 hasAuthorship W2561875875A5002381343 @default.
• W2561875875 hasAuthorship W2561875875A5035821112 @default.
• W2561875875 hasAuthorship W2561875875A5044224344 @default.
• W2561875875 hasAuthorship W2561875875A5044355450 @default.
• W2561875875 hasAuthorship W2561875875A5055349649 @default.
• W2561875875 hasAuthorship W2561875875A5072253025 @default.
• W2561875875 hasAuthorship W2561875875A5083844423 @default.
• W2561875875 hasConcept C10205521 @default.
• W2561875875 hasConcept C109159458 @default.
• W2561875875 hasConcept C201750760 @default.
• W2561875875 hasConcept C203014093 @default.
• W2561875875 hasConcept C2776090121 @default.
• W2561875875 hasConcept C2776706248 @default.
• W2561875875 hasConcept C2778170410 @default.
• W2561875875 hasConcept C2778513237 @default.
• W2561875875 hasConcept C2779727006 @default.
• W2561875875 hasConcept C2780007613 @default.
• W2561875875 hasConcept C28328180 @default.
• W2561875875 hasConcept C515207424 @default.
• W2561875875 hasConcept C55493867 @default.
• W2561875875 hasConcept C79484868 @default.
• W2561875875 hasConcept C83478079 @default.
• W2561875875 hasConcept C86803240 @default.
• W2561875875 hasConcept C8891405 @default.
• W2561875875 hasConcept C95444343 @default.
• W2561875875 hasConceptScore W2561875875C10205521 @default.
• W2561875875 hasConceptScore W2561875875C109159458 @default.
• W2561875875 hasConceptScore W2561875875C201750760 @default.
• W2561875875 hasConceptScore W2561875875C203014093 @default.
• W2561875875 hasConceptScore W2561875875C2776090121 @default.
• W2561875875 hasConceptScore W2561875875C2776706248 @default.
• W2561875875 hasConceptScore W2561875875C2778170410 @default.
• W2561875875 hasConceptScore W2561875875C2778513237 @default.
• W2561875875 hasConceptScore W2561875875C2779727006 @default.
• W2561875875 hasConceptScore W2561875875C2780007613 @default.
• W2561875875 hasConceptScore W2561875875C28328180 @default.
• W2561875875 hasConceptScore W2561875875C515207424 @default.
• W2561875875 hasConceptScore W2561875875C55493867 @default.
• W2561875875 hasConceptScore W2561875875C79484868 @default.
• W2561875875 hasConceptScore W2561875875C83478079 @default.
• W2561875875 hasConceptScore W2561875875C86803240 @default.
• W2561875875 hasConceptScore W2561875875C8891405 @default.
• W2561875875 hasConceptScore W2561875875C95444343 @default.
• W2561875875 hasIssue "21" @default.
• W2561875875 hasLocation W25618758751 @default.
• W2561875875 hasOpenAccess W2561875875 @default.
• W2561875875 hasPrimaryLocation W25618758751 @default.
• W2561875875 hasRelatedWork W1998228373 @default.
• W2561875875 hasRelatedWork W2011700548 @default.
• W2561875875 hasRelatedWork W2027927113 @default.
• W2561875875 hasRelatedWork W2054167115 @default.
• W2561875875 hasRelatedWork W2063113696 @default.
• W2561875875 hasRelatedWork W2097466377 @default.
• W2561875875 hasRelatedWork W2156396639 @default.
• W2561875875 hasRelatedWork W2322667139 @default.
• W2561875875 hasRelatedWork W2358325675 @default.
• W2561875875 hasRelatedWork W2561875875 @default.
• W2561875875 hasVolume "118" @default.
• W2561875875 isParatext "false" @default.
• W2561875875 isRetracted "false" @default.
• W2561875875 magId "2561875875" @default.
• W2561875875 workType "article" @default.